Acadia Pharmaceuticals Files 8-K on Financials
Ticker: ACAD · Form: 8-K · Filed: May 7, 2025 · CIK: 1070494
| Field | Detail |
|---|---|
| Company | Acadia Pharmaceuticals Inc (ACAD) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: ACAD
TL;DR
ACADIA filed an 8-K on 5/7/25 for financial updates.
AI Summary
On May 7, 2025, Acadia Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Acadia Pharmaceuticals is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- ACADIA PHARMACEUTICALS INC (company) — Filer
- May 07, 2025 (date) — Date of Report
- 0000950170-25-065672 (filing_id) — Accession Number
- 12830 El Camino Real, Suite 400, San Diego, California 92130 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Acadia Pharmaceuticals Inc.?
The primary purpose of this 8-K filing is to report on Acadia Pharmaceuticals Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on May 07, 2025.
What is Acadia Pharmaceuticals Inc.'s principal executive office address?
Acadia Pharmaceuticals Inc.'s principal executive office is located at 12830 El Camino Real, Suite 400, San Diego, California 92130.
What is the SEC file number for Acadia Pharmaceuticals Inc.?
The SEC file number for Acadia Pharmaceuticals Inc. is 000-50768.
What is the Standard Industrial Classification (SIC) code for Acadia Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Acadia Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding ACADIA PHARMACEUTICALS INC (ACAD).